Anthropocene Reviewed Podcast, tryanny of non-inferiority trials and a mini-tutorial on non-inferiority trials, GY-005 results, ENGOT-OV41 ANITA trial
Mucinous Ovarian Carcinoma
GOG 241: Phase III Randomized Trial in Patients with Mucinous Epithelial Ovarian Cancer
Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.
Vulvar Melanoma
Publications Update # 74
FIGO 2023 staging system for endometrial cancer - a deep dive.